openPR Logo
Press release

New App detects dementia risks early

12-11-2018 10:15 AM CET | Health & Medicine

Press release from: DST

The DST is certified as a Medical Device

The DST is certified as a Medical Device

• The App is certified as a Medical Device.
• Early stages are reliably detected, before the brain damage becomes irreversible.
• Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%).
• Now available for free during pre-launch.

Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia.
Therefore, effective screening tests are needed to detect early stages reliably, and to start treatment before the brain damages become irreversible.

A group of physicians has therefore developed a simple test - the DST - Dementia Screening Test. The reliability of the test results has been confirmed in clinical studies, and the test has therefore been recognized as a medical device by the competent authorities throughout the EU, Switzerland, Iceland, Norway, Liechtenstein, New Zealand, Canada and Australia.

Since 10 Dec 2018, the DST is now available as an App for any standard smartphone or tablet. So it can be performed easily and quickly at home. The app identifies the individual dementia risk, provides recommendations for reducing the risk, and documents changes over time.

The developers put great emphasize on reliable results, ease of use, and complete data security. No registration is required, no personal information is collected, and the test results are stored only on the tablet or smartphone used, but not on a central server. Of course, an overview of the results can be exported and thus presented to a physician to discuss further diagnostic and / or therapeutic measures before the brain damage becomes irreversible

Dr. Horn is Medical Doctor with a special passion for adressing unmet medical needs of the future.

Contact for questions
Dr. med. Sebastian Horn
Friedrichstr. 67, 10117 Berlin, Germany
T. 0152 - 55834551
horn@demenz-test.com
www.demenz-test.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New App detects dementia risks early here

News-ID: 1429758 • Views: 465

More Releases from DST

12-19-2019 | Health & Medicine
DST
Dementia screening and prevention – hope or hype?
It is estimated that about 50% of dementia patients do not receive a formal diagnosis. And when the diagnosis is made, it often happens at a time when the disease is well advanced and brain damages are irreversible. A major reason for this is that systematic dementia screening and prevention programmes are not yet ready for implementation as large-scale public health interventions. A key reason for this is the desire
07-10-2019 | Health & Medicine
DST
Dementia begins in the mid-40s - early detection crucial
We know today that those who will probably be demented in 15 to 20 years are already experiencing their first brain changes today. In other words, in many people it is already clear at the age of 40 to 50 whether they start to develop dementia. Fortunately, our brain can compensate individual deficits so well for 15 to 20 years that the affected person and the environment do not notice
02-11-2019 | Health & Medicine
DST
Dementia test predicts disease 18 years before symptoms
• Multi-dimensional cognitive tests detect restrictions at least 18 years prior to clinical Dementia symptoms. • Good therapy options exist for this pre-symptomatic phase. It has been known for several years that cognitive tests can "predict" dementia 10-12 years prior to clinical symptoms - or more precisely: they can recognize initial limitations in people who are not clinically conspicuous / symptomatic in everyday life, but who are later diagnosed with dementia. The
01-08-2019 | Health & Medicine
DST
Early Dementia detection via App receives medical device status
- The DST (Dementia Screening Test) App has been recognized by Health Authorities as a Medical Device. - Early Dementia stages are reliably detected, before the brain damages become irreversible. - Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%). Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today, there is no effective therapy for advanced stages of dementia. Therefore, effective screening

All 4 Releases


More Releases for Medical

ECG Analysis System Market Outlook: 2020 The Year On A Positive Note | GE Medica …
DataIntelo report titled Global ECG Analysis System Market provides detailed information and overview about the key influential factors required to make well informed business decision. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of
Medical Tracheostomy Tube Market Overall Study Report 2020-2027 | Players Medtro …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Medical Tracheostomy Tube Market. The research report "Global Medical Tracheostomy Tube Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Medical Tracheostomy Tube market and the current trends that are likely to shape its future.
Global Embolization Particle Market 2019 - Sirtex Medical, Merit Medical, Cook M …
The global "Embolization Particle Market" report delivers a comprehensive and systematic framework of the Embolization Particle market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Embolization Particle market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The
Medical Casting & Splinting Market 2019: Top Key players are 3M, DJO Global, BSN …
Medical Casting & Splinting Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13718924 Global Medical Casting & Splinting market 2019 research provides a basic overview of
Global Embolization Particle Industry 2018 - Sirtex Medical, Merit Medical, Cook …
The Global Embolization Particle Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Embolization Particle industry. Firstly, Embolization Particle Market report provides a basic overview of the Embolization Particle industry including definitions, classifications, applications and Embolization Particle industry chain structure. Global Embolization Particle Market analysis is provided for the international market including development history, Embolization Particle industry competitive landscape analysis, and major regions
Global Oxygen Pressure Regulator Market 2017 : Precision Medical, Smiths Medical …
Oxygen Pressure Regulator A market study based on the " Oxygen Pressure Regulator Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Oxygen Pressure Regulator Market 2017’. The research report analyses the historical as well as present performance of the worldwide Oxygen Pressure Regulator industry, and makes predictions on the future status of Oxygen Pressure Regulator market on the basis of this analysis. Get Free